Australia markets closed

Lexaria Bioscience Corp. (LEXX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.3300+0.2000 (+6.37%)
As of 09:37AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (May 2024)Next qtr. (Aug 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.13-0.12-0.46-0.44
Low estimate-0.13-0.13-0.47-0.48
High estimate-0.13-0.12-0.46-0.41
Year ago EPS-0.37-0.12-1.01-0.46
Revenue estimateCurrent qtr. (May 2024)Next qtr. (Aug 2024)Current year (2024)Next year (2025)
No. of analysts1121
Avg. Estimate150k150k370k970k
Low estimate150k150k150k970k
High estimate150k150k600k970k
Year ago salesN/AN/A226k370k
Sales growth (year/est)N/AN/A63.70%162.20%
Earnings history30/05/202330/08/202329/11/202328/02/2024
Est. EPS-0.25-0.13-0.11-0.1
Actual EPS-0.37-0.12-0.13-0.06
Difference-0.120.01-0.020.04
Surprise %-48.00%7.70%-18.20%40.00%
EPS trendCurrent qtr. (May 2024)Next qtr. (Aug 2024)Current year (2024)Next year (2025)
Current estimate-0.13-0.12-0.46-0.44
7 days ago-0.13-0.12-0.53-0.49
30 days ago-0.13-0.12-0.53-0.49
60 days ago-0.13-0.12-0.53-0.49
90 days ago-0.15-0.11-0.54-0.46
EPS revisionsCurrent qtr. (May 2024)Next qtr. (Aug 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/A11
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLEXXIndustrySector(s)S&P 500
Current qtr.64.90%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year54.50%N/AN/AN/A
Next year4.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A